These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 22715033

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. What is next in nitric oxide research? From cardiovascular system to cancer biology.
    Bian K, Murad F.
    Nitric Oxide; 2014 Dec 01; 43():3-7. PubMed ID: 25153032
    [Abstract] [Full Text] [Related]

  • 3. Structure and regulation of soluble guanylate cyclase.
    Derbyshire ER, Marletta MA.
    Annu Rev Biochem; 2012 Dec 01; 81():533-59. PubMed ID: 22404633
    [Abstract] [Full Text] [Related]

  • 4. Impaired iNOS-sGC-cGMP signalling contributes to chronic hypoxic and hypercapnic pulmonary hypertension in rat.
    Xia XD, Xu ZJ, Hu XG, Wu CY, Dai YR, Yang L.
    Cell Biochem Funct; 2012 Jun 01; 30(4):279-85. PubMed ID: 22290599
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Human soluble guanylate cyclase as a nitric oxide sensor for NO-signalling reveals a novel function of nitrite reductase.
    Pan J, Xu Q, Lin YW, Zhong F, Tan X.
    Chem Commun (Camb); 2013 Aug 28; 49(67):7454-6. PubMed ID: 23864033
    [Abstract] [Full Text] [Related]

  • 8. Characterization of nitric oxide signaling pathways in the mouse retina.
    Blom J, Giove T, Deshpande M, Eldred WD.
    J Comp Neurol; 2012 Dec 15; 520(18):4204-17. PubMed ID: 22592770
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Molecular variants of soluble guanylyl cyclase affecting cardiovascular risk.
    Wobst J, Rumpf PM, Dang TA, Segura-Puimedon M, Erdmann J, Schunkert H.
    Circ J; 2015 Dec 15; 79(3):463-9. PubMed ID: 25746521
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cyclic GMP-dependent protein kinase and soluble guanylyl cyclase disappear in elicited rat neutrophils.
    Ciuman M, Siednienko J, Czyzyk R, Witwicka H, Kołosionek E, Kobiałka M, Gorczyca WA.
    Biochim Biophys Acta; 2006 Nov 15; 1760(11):1618-23. PubMed ID: 17045402
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of sGC-dependent NO signalling and myocardial infarction risk.
    Wobst J, Kessler T, Dang TA, Erdmann J, Schunkert H.
    J Mol Med (Berl); 2015 Apr 15; 93(4):383-94. PubMed ID: 25733135
    [Abstract] [Full Text] [Related]

  • 19. sGC-cGMP signaling: target for anticancer therapy.
    Bian K, Murad F.
    Adv Exp Med Biol; 2014 Apr 15; 814():5-13. PubMed ID: 25015797
    [Abstract] [Full Text] [Related]

  • 20. Spontaneous and receptor-controlled soluble guanylyl cyclase activity in anterior pituitary cells.
    Kostic TS, Andric SA, Stojilkovic SS.
    Mol Endocrinol; 2001 Jun 15; 15(6):1010-22. PubMed ID: 11376118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.